281 related articles for article (PubMed ID: 29218504)
21. The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats.
Li M; Zhou M; Wen P; Wang Q; Yang Y; Xiao H; Xie Z; Li X; Wang N; Wang J; Luo F; Chang J; Zhang W
Exp Neurol; 2016 Aug; 282():27-36. PubMed ID: 27163550
[TBL] [Abstract][Full Text] [Related]
22. Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients?
Heise CE; Teo ZC; Wallace BA; Ashkan K; Benabid AL; Mitrofanis J
Anat Embryol (Berl); 2005 Nov; 210(4):287-302. PubMed ID: 16237536
[TBL] [Abstract][Full Text] [Related]
23. G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system.
Xiao Q; Yang S; Le W
J Neural Transm (Vienna); 2015 Dec; 122(12):1645-57. PubMed ID: 26253900
[TBL] [Abstract][Full Text] [Related]
24. The effect of low frequency stimulation of the pedunculopontine tegmental nucleus on basal ganglia in a rat model of Parkinson's disease.
Park E; Song I; Jang DP; Kim IY
Neurosci Lett; 2014 Aug; 577():16-21. PubMed ID: 24928224
[TBL] [Abstract][Full Text] [Related]
25. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
Breit S; Lessmann L; Benazzouz A; Schulz JB
Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
[TBL] [Abstract][Full Text] [Related]
26. Low-frequency stimulation of the pedunculopontine nucleus affects gait and the neurotransmitter level in the ventrolateral thalamic nucleus in 6-OHDA Parkinsonian rats.
Wen P; Li M; Xiao H; Ding R; Chen H; Chang J; Zhou M; Yang Y; Wang J; Zheng W; Zhang W
Neurosci Lett; 2015 Jul; 600():62-8. PubMed ID: 26054938
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease.
Bury AG; Pyle A; Elson JL; Greaves L; Morris CM; Hudson G; Pienaar IS
Ann Neurol; 2017 Dec; 82(6):1016-1021. PubMed ID: 29149768
[TBL] [Abstract][Full Text] [Related]
28. Effect of l-DOPA on local field potential relationship between the pedunculopontine nucleus and primary motor cortex in a rat model of Parkinson's disease.
Geng X; Wang X; Xie J; Zhang X; Wang X; Hou Y; Lei C; Li M; Han H; Yao X; Zhang Q; Wang M
Behav Brain Res; 2016 Dec; 315():1-9. PubMed ID: 27515286
[TBL] [Abstract][Full Text] [Related]
29. Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease.
Aravamuthan BR; Bergstrom DA; French RA; Taylor JJ; Parr-Brownlie LC; Walters JR
Exp Neurol; 2008 Oct; 213(2):268-80. PubMed ID: 18601924
[TBL] [Abstract][Full Text] [Related]
30. High-frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat.
Florio T; Scarnati E; Confalone G; Minchella D; Galati S; Stanzione P; Stefani A; Mazzone P
Eur J Neurosci; 2007 Feb; 25(4):1174-86. PubMed ID: 17331213
[TBL] [Abstract][Full Text] [Related]
31. Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA.
Konieczny J; Czarnecka A; Kamińska K; Lenda T; Nowak P
Behav Brain Res; 2015 Apr; 283():203-14. PubMed ID: 25655509
[TBL] [Abstract][Full Text] [Related]
32. Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease.
Pienaar IS; Elson JL; Racca C; Nelson G; Turnbull DM; Morris CM
Am J Pathol; 2013 Dec; 183(6):1826-1840. PubMed ID: 24099985
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
Rolland AS; Tandé D; Herrero MT; Luquin MR; Vazquez-Claverie M; Karachi C; Hirsch EC; François C
J Neurochem; 2009 Aug; 110(4):1321-9. PubMed ID: 19527435
[TBL] [Abstract][Full Text] [Related]
34. GABAergic neuron distribution in the pedunculopontine nucleus defines functional subterritories.
Mena-Segovia J; Micklem BR; Nair-Roberts RG; Ungless MA; Bolam JP
J Comp Neurol; 2009 Aug; 515(4):397-408. PubMed ID: 19459217
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
Carriere CH; Kang NH; Niles LP
Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
[TBL] [Abstract][Full Text] [Related]
36. [Effects and mechanism of low frequency stimulation of pedunculopontine nucleus on spontaneous discharges of ventrolateral thalamic nucleus in rats].
Liu H; Lin YH; Cheng JH; Cai Y; Yu JW; Ma J; Gao DM
Sheng Li Xue Bao; 2011 Aug; 63(4):311-8. PubMed ID: 21861049
[TBL] [Abstract][Full Text] [Related]
37. Presence of proNGF-sortilin signaling complex in nigral dopamine neurons and its variation in relation to aging, lactacystin and 6-OHDA insults.
Xia Y; Chen BY; Sun XL; Duan L; Gao GD; Wang JJ; Yung KK; Chen LW
Int J Mol Sci; 2013 Jul; 14(7):14085-104. PubMed ID: 23880857
[TBL] [Abstract][Full Text] [Related]
38. Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry.
Mackey S; Jing Y; Flores J; Dinelle K; Doudet DJ
Exp Neurol; 2013 Sep; 247():19-24. PubMed ID: 23557600
[TBL] [Abstract][Full Text] [Related]
39. Nigral degeneration with inclusion body formation and behavioral changes in rats after proteasomal inhibition.
Niu C; Mei J; Pan Q; Fu X
Stereotact Funct Neurosurg; 2009; 87(2):69-81. PubMed ID: 19223692
[TBL] [Abstract][Full Text] [Related]
40. The firing activity of presumed cholinergic and non-cholinergic neurons of the pedunculopontine nucleus in 6-hydroxydopamine-lesioned rats: an in vivo electrophysiological study.
Zhang QJ; Liu J; Wang Y; Wang S; Wu ZH; Yan W; Hui YP; Ali U
Brain Res; 2008 Dec; 1243():152-60. PubMed ID: 18824158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
